Their paper, "A humanized antibody against mucormycosis targets angioinvasion and augments the host immune response," was recently accepted and published in the Science Translational Medicine journal.

More information: Ryota Sada et al, Newly developed humanized anti‐CKAP4 antibody suppresses pancreatic cancer growth by inhibiting DKK1‐CKAP4 signaling, Cancer Science (2024). DOI: 10.1111 ...

Humanized antibodies have generated encouraging results for treating diseases that require long-term treatment, such as cancer and infectious diseases. Single B cell and phage display technologies ...

The drug is indicated for the treatment rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic ...

High throughput production of chimeric antibodies with murine-constant regions and human-variable regions has tremendous implications for both research and clinical purposes. Download this poster from ...

Early tests suggest that an antibody-based therapy is safe, with no harmful effects on healthy cells, suggesting that it could be a promising treatment to help fight mucormycosis in people with ...

A recent study explored the therapeutic potential of hu128.1, a humanized antibody targeting transferrin receptor 1 (TfR1), in treating erythroleukemia using xenograft mouse models. The results ...

As SARS-CoV-2 has evolved and mutated, therapeutic antibodies that worked early in the pandemic have become less effective, and newer variants, especially Omicron, have developed ways to evade the ...